A Study of MHB036C for Advanced Solid Tumor
Clinical trial NCT06373406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06373406
- Sponsor
- Minghui Pharmaceutical (Hangzhou) Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2025-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.